Renaissance Technologies LLC Grows Stock Holdings in National Research Co. (NASDAQ:NRC)

Renaissance Technologies LLC increased its position in shares of National Research Co. (NASDAQ:NRCFree Report) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 404,886 shares of the company’s stock after acquiring an additional 25,002 shares during the quarter. Renaissance Technologies LLC owned about 1.72% of National Research worth $7,142,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. PNC Financial Services Group Inc. increased its position in shares of National Research by 2,250.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company’s stock worth $27,000 after purchasing an additional 1,463 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in National Research in the fourth quarter valued at about $50,000. FMR LLC raised its stake in National Research by 397.3% in the third quarter. FMR LLC now owns 2,944 shares of the company’s stock valued at $67,000 after buying an additional 2,352 shares during the last quarter. Signaturefd LLC boosted its holdings in National Research by 613.3% in the fourth quarter. Signaturefd LLC now owns 4,173 shares of the company’s stock worth $74,000 after acquiring an additional 3,588 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its stake in shares of National Research by 219.3% during the fourth quarter. Quadrant Capital Group LLC now owns 5,006 shares of the company’s stock worth $88,000 after acquiring an additional 3,438 shares during the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Performance

Shares of National Research stock opened at $10.54 on Friday. The firm has a market capitalization of $241.85 million, a P/E ratio of 10.04 and a beta of 0.41. National Research Co. has a 52 week low of $10.40 and a 52 week high of $35.81. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The company has a 50 day moving average price of $14.04 and a 200 day moving average price of $16.88.

National Research (NASDAQ:NRCGet Free Report) last posted its quarterly earnings data on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.55%. The ex-dividend date was Friday, March 28th. National Research’s dividend payout ratio (DPR) is 45.71%.

National Research Profile

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Further Reading

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.